Keywords
Last Name
Institution

ROBERT COLLINS

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Neurology
DivisionNeurology
Address2002 HOLCOMBE BLVD. (153)
HOUSTON TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Khoury HJ, Collins RH, Blum W, Stiff PS, Elias L, Lebkowski JS, Reddy A, Nishimoto KP, Sen D, Wirth ED, Case CC, DiPersio JF. Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia. Cancer. 2017 Apr 14. PMID: 28411378.
      View in: PubMed
    2. Brown TJ, Gentry C, Hammer ST, Hwang CS, Vusirikala M, Patel PA, Matevosyan K, Tujios SR, Mufti AR, Collins RH. Novel Application of Extracorporeal Photopheresis as Treatment of Graft-versus-Host Disease Following Liver Transplantation. ACG Case Rep J. 2017; 4:e48. PMID: 28377936.
      View in: PubMed
    3. Carey A, Edwards DK, Eide CA, Newell L, Traer E, Medeiros BC, Pollyea DA, Deininger MW, Collins RH, Tyner JW, Druker BJ, Bagby GC, McWeeney SK, Agarwal A. Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia. Cell Rep. 2017 Mar 28; 18(13):3204-3218. PMID: 28355571.
      View in: PubMed
    4. Dietrich MF, Collins RH, Gerber DE. Next-Generation Sequencing for the Identification of Targetable Molecular Alterations in Cancer. JAMA Oncol. 2016 Jan; 2(1):132-3. PMID: 26426250.
      View in: PubMed
    5. McGehee E, Rakheja D, Oliver D, Chen W, Boriack R, Collins RH. The importance of plasma D-2HG measurement in screening for IDH mutations in acute myeloid leukaemia. Br J Haematol. 2016 Apr; 173(2):323-6. PMID: 26195003.
      View in: PubMed
    6. Kang X, Lu Z, Cui C, Deng M, Fan Y, Dong B, Han X, Xie F, Tyner JW, Coligan JE, Collins RH, Xiao X, You MJ, Zhang CC. The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development. Nat Cell Biol. 2015 May; 17(5):665-77. PMID: 25915125; PMCID: PMC4417000.
    7. Wang M, Popplewell LL, Collins RH, Winter JN, Goy A, Kaminski MS, Bartlett NL, Johnston PB, Lister J, Fanning SR, Tuscano JM, Beck JT, Kaya H, Robeva A, Fan J, Klimovsky J, Cheung W, Cherfi A, O'Connor OA. Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study. Br J Haematol. 2014 May; 165(4):510-8. PMID: 24579926.
      View in: PubMed
    8. Naina HV, Levitt D, Vusirikala M, Anderson LD, Scaglioni PP, Kirk A, Collins RH. Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene. J Clin Oncol. 2011 Jun 20; 29(18):e534-6. PMID: 21482998.
      View in: PubMed
    9. Tirado CA, Chen W, Valdez F, Karandikar N, Arbini A, Acevedo I, Garcia R, Davila O, Smart RL, Matthews E, Kirk A, Collins RH. Unusual presentation of myeloid sarcoma in a case of acute promyelocytic leukemia with a cryptic PML-RARA rearrangement involving multiple sites including the atrium. Cancer Genet Cytogenet. 2010 Jul 1; 200(1):47-53. PMID: 20513534.
      View in: PubMed
    10. Tirado CA, Chen W, Valdez FJ, Henderson S, Doolittle J, Garcia R, Patel S, Holdridge S, Chastain C, Collins RH. Acute myeloid leukemia (M2) with a cryptic RUNX1/RUNX1T1 t(1;21;8)(p36;q22;q22) variant. Cancer Genet Cytogenet. 2009 Aug; 193(1):67-9. PMID: 19602466.
      View in: PubMed
    11. Tirado CA, Chena W, Valdez FJ, Henderson S, Smart RL, Doolittle J, Garcia R, Patel S, Holdridge S, Chastain C, Auchus M, Collins RH. A Cryptic t(1;21;8)(p36;q22;q22) in a Case of Acute Myeloid Leukemia with Maturation. J Assoc Genet Technol. 2009; 35(3):88-92. PMID: 19738329.
      View in: PubMed
    12. Shah NP, Kantarjian HM, Kim DW, Réa D, Dorlhiac-Llacer PE, Milone JH, Vela-Ojeda J, Silver RT, Khoury HJ, Charbonnier A, Khoroshko N, Paquette RL, Deininger M, Collins RH, Otero I, Hughes T, Bleickardt E, Strauss L, Francis S, Hochhaus A. Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia. J Clin Oncol. 2008 Jul 1; 26(19):3204-12. PMID: 18541900.
      View in: PubMed
    13. Sathe A, Ortega SB, Mundy DI, Collins RH, Karandikar NJ. In vitro methotrexate as a practical approach to selective allodepletion. Biol Blood Marrow Transplant. 2007 Jun; 13(6):644-54. PMID: 17531774.
      View in: PubMed
    14. Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA, Territo MC, Collins RH, McSweeney PA, Copelan EA, Khan SP, Woolfrey A, Storer B. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood. 2006 Sep 1; 108(5):1485-91. PMID: 16684959; PMCID: PMC1895515.
    15. Butcher BW, Collins RH. The graft-versus-lymphoma effect: clinical review and future opportunities. Bone Marrow Transplant. 2005 Jul; 36(1):1-17. PMID: 15895112.
      View in: PubMed
    16. Butcher BW, Wilson KS, Kroft SH, Collins RH, Bhushan V. Acute leukemia with B-lymphoid and myeloid differentiation associated with an inv(5)(q13q33) in an adult patient. Cancer Genet Cytogenet. 2005 Feb; 157(1):62-6. PMID: 15676149.
      View in: PubMed
    17. Bhushan V, Collins RH. Chronic graft-vs-host disease. JAMA. 2003 Nov 19; 290(19):2599-603. PMID: 14625337.
      View in: PubMed
    18. Michálek J, Collins RH, Hill BJ, Brenchley JM, Douek DC. Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation. Lancet. 2003 Apr 5; 361(9364):1183-5. PMID: 12686042.
      View in: PubMed
    19. Aquino VM, Douek DC, Berryman B, Johnson M, Jain VK, Collins RH. Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine. Leuk Lymphoma. 2003 Feb; 44(2):343-8. PMID: 12688355.
      View in: PubMed
    20. Michalek J, Collins RH, Durrani HP, Vaclavkova P, Ruff LE, Douek DC, Vitetta ES. Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences. Proc Natl Acad Sci U S A. 2003 Feb 4; 100(3):1180-4. PMID: 12531922; PMCID: PMC298747.
    21. Michálek J, Collins RH, Vitetta ES. Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin. Neoplasma. 2003; 50(4):296-9. PMID: 12937844.
      View in: PubMed
    22. Xu Y, McKenna RW, Hoang MP, Collins RH, Kroft SH. Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature. Am J Clin Pathol. 2002 Dec; 118(6):848-54. PMID: 12472277.
      View in: PubMed
    23. Levine JE, Braun T, Penza SL, Beatty P, Cornetta K, Martino R, Drobyski WR, Barrett AJ, Porter DL, Giralt S, Leis J, Holmes HE, Johnson M, Horowitz M, Collins RH. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. J Clin Oncol. 2002 Jan 15; 20(2):405-12. PMID: 11786567.
      View in: PubMed
    24. Weinberg K, Blazar BR, Wagner JE, Agura E, Hill BJ, Smogorzewska M, Koup RA, Betts MR, Collins RH, Douek DC. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001 Mar 1; 97(5):1458-66. PMID: 11222394.
      View in: PubMed
    25. Malik AH, Collins RH, Saboorian MH, Lee WM. Chronic graft-versus-host disease after hematopoietic cell transplantation presenting as an acute hepatitis. Am J Gastroenterol. 2001 Feb; 96(2):588-90. PMID: 11232714.
      View in: PubMed
    26. Salama M, Nevill T, Marcellus D, Parker P, Johnson M, Kirk A, Porter D, Giralt S, Levine JE, Drobyski W, Barrett AJ, Horowitz M, Collins RH. Donor leukocyte infusions for multiple myeloma. Bone Marrow Transplant. 2000 Dec; 26(11):1179-84. PMID: 11149728.
      View in: PubMed
    27. Gatlin J, Douglas J, Evans JT, Collins RH, Wendel GD, Garcia JV. In vitro selection of lentivirus vector-transduced human CD34+ cells. Hum Gene Ther. 2000 Sep 1; 11(13):1949-57. PMID: 10986566.
      View in: PubMed
    28. Collins RH, Goldstein S, Giralt S, Levine J, Porter D, Drobyski W, Barrett J, Johnson M, Kirk A, Horowitz M, Parker P. Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant. 2000 Sep; 26(5):511-6. PMID: 11019840.
      View in: PubMed
    29. Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L, Berenson JR, Collins RH, Koup RA. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet. 2000 May 27; 355(9218):1875-81. PMID: 10866444.
      View in: PubMed
    30. Porter DL, Collins RH, Hardy C, Kernan NA, Drobyski WR, Giralt S, Flowers ME, Casper J, Leahey A, Parker P, Mick R, Bate-Boyle B, King R, Antin JH. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood. 2000 Feb 15; 95(4):1214-21. PMID: 10666193.
      View in: PubMed
    31. Fleming DR, Wolff SN, Fay JW, Brown RA, Lynch JP, Bolwell BJ, Stevens DA, Goodman SA, Greer JP, Stein RS, Pineiro LA, Collins RH, Goldsmith LJ, Herzig GP, Herzig RH. Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group. Leuk Lymphoma. 1999 Sep; 35(1-2):91-8. PMID: 10512166.
      View in: PubMed
    32. Porter DL, Collins RH, Shpilberg O, Drobyski WR, Connors JM, Sproles A, Antin JH. Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions. Biol Blood Marrow Transplant. 1999; 5(4):253-61. PMID: 10465105.
      View in: PubMed
    33. Collins RH, Piñeiro LA, Agura ED, Fay JW. Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation. Bone Marrow Transplant. 1998 Mar; 21(6):627-8. PMID: 9580345.
      View in: PubMed
    34. Collins RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol. 1997 Feb; 15(2):433-44. PMID: 9053463.
      View in: PubMed
    35. Collins RH, Sackler M, Pitcher CJ, Waldrop SL, Klintmalm GB, Jenkins R, Picker LJ. Immune reconstitution with donor-derived memory/effector T cells after orthotopic liver transplantation. Exp Hematol. 1997 Feb; 25(2):147-59. PMID: 9015215.
      View in: PubMed
    36. Stone MJ, Sausville EA, Fay JW, Headlee D, Collins RH, Figg WD, Stetler-Stevenson M, Jain V, Jaffe ES, Solomon D, Lush RM, Senderowicz A, Ghetie V, Schindler J, Uhr JW, Vitetta ES. A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. Blood. 1996 Aug 15; 88(4):1188-97. PMID: 8695836.
      View in: PubMed
    37. Brown RA, Wolff SN, Fay JW, Pineiro L, Collins RH, Lynch JP, Stevens D, Greer J, Herzig RH, Herzig GP. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group. Leuk Lymphoma. 1996 Jul; 22(3-4):271-7. PMID: 8819076.
      View in: PubMed
    38. Fay JW, Wingard JR, Antin JH, Collins RH, Piñeiro LA, Blazar BR, Saral R, Bierer BE, Przepiorka D, Fitzsimmons WE, Maher RM, Weisdorf DJ. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. Blood. 1996 Apr 15; 87(8):3514-9. PMID: 8605372.
      View in: PubMed
    39. Collins RH, Pineiro LA, Nemunaitis JJ, Jain VK, Waxman D, Miller WV, Fay JW. Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation. Transfusion. 1995 Nov-Dec; 35(11):891-8. PMID: 8604484.
      View in: PubMed
    40. Brown RA, Wolff SN, Fay JW, Pineiro L, Collins RH, Lynch JP, Stevens D, Greer J, Herzig RH, Herzig GP. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group. Blood. 1995 Mar 1; 85(5):1391-5. PMID: 7858269.
      View in: PubMed
    41. Fay JW, Nash RA, Wingard JR, Przepiorka D, Collins RH, Anasetti C, Devine SM, Piñeiro LA, Storb RF, Aro RM, et al. FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation. Transplant Proc. 1995 Feb; 27(1):1374. PMID: 7533383.
      View in: PubMed
    42. Nikaein A, Collins RH, Klintmalm G, Poole T, Fay JW, Stone MJ. Immunologic monitoring of graft-versus-host disease following orthotopic liver transplantation. Transplantation. 1994 Feb 27; 57(4):637-40. PMID: 8116054.
      View in: PubMed
    43. Wolff SN, Fay JW, Herzig RH, Greer JP, Dummer S, Brown RA, Collins RH, Stevens DA, Herzig GP. High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group. Ann Intern Med. 1993 Jun 15; 118(12):937-42. PMID: 8489107.
      View in: PubMed
    44. Collins RH, Anastasi J, Terstappen LW, Nikaein A, Feng J, Fay JW, Klintmalm G, Stone MJ. Brief report: donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient. N Engl J Med. 1993 Mar 18; 328(11):762-5. PMID: 8094887.
      View in: PubMed
    45. Fay JW, Collins RH, Piñeiro L. Allogeneic bone marrow transplantation using unrelated marrow donors. Bone Marrow Transplant. 1993; 11 Suppl 1:81-2. PMID: 8448557.
      View in: PubMed
    46. Collins RH, Rogers ZR, Bennett M, Kumar V, Nikein A, Fay JW. Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression. Bone Marrow Transplant. 1992 Oct; 10(4):391-5. PMID: 1422499.
      View in: PubMed
    47. Collins RH, White CS, Stringer CA, Fay JW. Successful treatment of refractory gestational trophoblastic neoplasm with high-dose etoposide and cyclophosphamide. Gynecol Oncol. 1991 Dec; 43(3):317-9. PMID: 1661266.
      View in: PubMed
    COLLINS's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _